Additional file 2 of Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
收藏数据链接：
官方服务：
资源简介：
Additional file 2: Supplementary Table 2a. Association of OS with selected variables. Supplementary Table 2b Association of OS with selected variables in multivariable analysis – Paired analysis.
附加文件2：补充表2a。选定变量与总生存期（Overall Survival, OS）的相关性。补充表2b：多变量分析中选定变量与总生存期的相关性——配对分析。
提供机构：
Ludek Pour创建时间：
2021-01-16
